Join the Cervical Cancer group to help and get support from people like you.
Cervical Cancer News
Related terms: Cancer, Cervix
Mailed Self-Collection Kits Increase Rates of Cervical Cancer Screening
WEDNESDAY, June 11, 2025 – Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA Internal Medicine. Jane R. M...
At-Home HPV Testing Boosts Cervical Cancer Screening Rates
WEDNESDAY, June 11, 2025 — Women will flock to an HPV test they can perform at home in private, a new study indicates. Cervical cancer screening more than doubled when women were offered a mail-in s...
Similar Survival Seen With Simple Versus Radical Hysterectomy for Cervical Cancer
WEDNESDAY, May 21, 2025 – For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical hysterectomy (MRH) or radical hysterectomy (RH),...
Testosterone Therapy Doesn't Increase Cancer Risk For Transmasculine People
FRIDAY, May 16, 2025 — Transmasculine and gender diverse people who use testosterone are not at an increased risk for cervical, ovarian or other gynecological cancers, a new study says. The results s...
FDA Approves At-Home Cervical Cancer Test for Women Ages 25 to 65
MONDAY, May 12, 2025 — Women now have a new way to check their risk for cervical cancer — from the comfort of their own home. The U.S. Food and Drug Administration (FDA) has approved the Teal Wand, an...
Rural-Urban Disparities Seen in Cervical Cancer
FRIDAY, March 7, 2025 – The incidence of and mortality from cervical cancer are higher among rural-residing women versus their urban counterparts within the United States, according to a research...
Cancer Screening Rates Rebound Post-Pandemic
THURSDAY, March 6, 2025 – Preventive screenings for cancer declined during the pandemic, with lockdowns, social distancing and COVID-19 surges keeping many from needed mammograms and colonoscopies....
2008 to 2022 Saw Declines in Cervical Precancers in Women Aged 20 to 24 Years
TUESDAY, March 4, 2025 – From 2008 to 2022, there were considerable decreases in the rates of cervical intraepithelial neoplasia (CIN) grades 2 to 3 and adenocarcinoma in situ (AIS; collectively...
Therapeutic Vaccine Shows Preliminary Safety, Effectiveness for HPV16+ Cervical Precancerous Condition
THURSDAY, Jan. 30, 2025 – For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a replication-incompetent Semliki...
Cancer Mortality Continued to Decline Through 2022
THURSDAY, Jan. 16, 2025 – Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among women, according to the Cancer Statistics, 2025 report...
Nonadherence to Cancer Screening Varies by Screening Type
THURSDAY, Jan. 9, 2025 – Nonadherence to cancer screening varies by screening type and sex, according to a study published online Jan. 3 in JAMA Network Open. Ami E. Sedani, Ph.D., M.P.H., from the...
Study Supports HPV Self-Testing for Cervical Cancer Screening
TUESDAY, Dec. 17, 2024 – A self-administered test can help empower women in identifying risks for cervical cancer. A new study published Dec. 12 in the journal PLOS Medicine shows the self-test for...
Task Force Supports Women Over 30 Collecting Samples for Cervical Cancer Screening
TUESDAY, Dec. 10, 2024 – In guidelines that may encourage more women to get screened for cervical cancer, a leading health task force has backed giving women over 30 the option to collect their own...
Screening Primary Driver of Averted Cancer Deaths From 1975 to 2020
TUESDAY, Dec. 10, 2024 – Over the past 45 years, cancer prevention and screening accounted for most cancer deaths averted for breast, cervical, colorectal, lung, and prostate cancers, according to a...
USPSTF Issues Draft Recommendation Statement for Cervical Cancer Screening
TUESDAY, Dec. 10, 2024 – The U.S. Preventive Services Task Force (USPSTF) recommends screening for cervical cancer, with different approaches recommended for those aged 21 to 29 years and 30 to 65...